INSMED IncINSM
Market cap
$41.3B
P/E ratio
| Dec 31, 2011 | Dec 31, 2012 | Dec 31, 2013 | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | |
| Product revenues, net | - | - | - | - | - | - | - | 10 | 136 | 164 | 188 | 245 | 305 | 364 |
| Cost of Goods and Services Sold | - | - | - | - | - | - | - | 2 | 24 | 40 | 44 | 55 | 66 | 86 |
| Research and development | 28 | 30 | 44 | 56 | 74 | 123 | 110 | 145 | 132 | 181 | 273 | 398 | 571 | 598 |
| Selling, general and administrative | - | - | - | - | - | - | - | - | - | - | - | - | - | 461 |
| Amortization of intangible assets | - | - | - | - | - | - | - | 1 | 5 | 5 | 5 | 5 | 5 | 5 |
| Change in fair value of deferred and contingent consideration liabilities | - | - | - | - | - | - | - | - | - | - | 7 | -21 | 29 | 92 |
| Total operating expenses | - | - | - | - | - | - | - | 317 | 348 | 430 | 564 | 703 | 1,015 | 1,242 |
| Operating loss | -62 | -42 | -55 | -87 | -117 | -173 | -189 | -307 | -235 | -265 | -375 | -457 | -710 | -878 |
| Investment income | 2 | 2 | 0 | 0 | 0 | 1 | 2 | 10 | 10 | 2 | 0 | 11 | 42 | 53 |
| Interest expense | - | - | - | - | - | - | - | - | - | - | - | - | - | 85 |
| Unrealized Gain (Loss) on Derivatives | - | - | - | - | - | - | - | - | - | - | - | -2 | 0 | -0 |
| Other income (expense), net | - | - | -0 | 0 | -0 | 0 | 0 | 1 | -1 | 0 | -3 | -6 | 2 | 0 |
| Loss before income taxes | - | - | - | - | - | -176 | -193 | -324 | -254 | -293 | -436 | -480 | -747 | -910 |
| Provision for income taxes | - | - | -1 | -10 | -2 | 0 | -0 | 0 | 1 | 1 | -2 | 1 | 3 | 4 |
| Net loss | -60 | -41 | -56 | -79 | -118 | -176 | -193 | -324 | -254 | -294 | -435 | -482 | -750 | -914 |
| Earnings Per Share, Basic | -2.95 | - | - | - | - | - | - | - | - | - | -3.88 | -3.91 | -5.34 | -5.57 |
| Earnings Per Share, Diluted | -2.95 | - | - | - | - | - | - | - | - | - | -3.88 | -3.91 | -5.34 | -5.57 |
| Net loss, basic | -69 | -41 | -56 | -79 | - | -176 | -193 | -324 | -254 | -294 | -435 | -482 | -750 | -914 |
| Net loss, diluted | - | - | - | - | - | - | - | - | - | - | - | - | - | -914 |
| Foreign currency translation and other (losses) gains | - | - | - | - | - | -0 | 0 | -0 | -0 | 0 | 1 | 0 | -2 | -2 |
| Unrealized gain (loss) on marketable securities | - | - | - | - | - | - | - | - | - | - | - | -1 | 1 | 0 |
| Total comprehensive loss | - | -41 | -56 | -79 | - | -176 | -193 | -324 | -254 | -294 | -434 | -482 | -751 | -915 |